Advertisement

Topics

CEL-SCI Corporation CEL-SCI Corporation Company Profile

06:40 EDT 23rd March 2019 | BioPortfolio

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the head and neck. Subject to the partial clinical hold, the study was designed with the objective that, if the study endpoint, which is an improvement in overall survival of the subjects treated with the Multikine treatment regimen plus the current standard of care (SOC) as compared to subjects treated with the current SOC only, is satisfied, the study results will be used to support applications that the Company plans to submit to regulatory agencies in order to seek commercial marketing approvals for Multikine in major markets around the world. CEL-SCI has patents on Multikine from the US, Europe, China, and Japan.


News Articles [382 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Olli Huotari

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Satu Ahomäki

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki   Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Virve Laitinen

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the f...

Orion Corporation: Managers' transactions - Christer Nordstedt

 ORION CORPORATION        MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has receiv...

Orion Corporation: Managers' transactions - Timo Lappalainen

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Jari Karlson

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the fol...

Orion Corporation: Managers' transactions - Markku Huhta-Koivisto

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has rec...

Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019

ORION CORPORATION      STOCK EXCHANGE RELEASE   1 MARCH 2019   at 19.10 EET             Orion Corporation: Transfer of 47,279 own B shares on 1 Ma...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [238 Associated Companies listed on BioPortfolio]

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

Immusoft Corporation

Immusoft Corporation’s (immusoft.com) mission is to treat diseases using its breakthrough technology platform called Immune System Programming (ISP™). The technology mod...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "CEL-SCI Corporation CEL-SCI Corporation" on BioPortfolio

We have published hundreds of CEL-SCI Corporation CEL-SCI Corporation news stories on BioPortfolio along with dozens of CEL-SCI Corporation CEL-SCI Corporation Clinical Trials and PubMed Articles about CEL-SCI Corporation CEL-SCI Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CEL-SCI Corporation CEL-SCI Corporation Companies in our database. You can also find out about relevant CEL-SCI Corporation CEL-SCI Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record